Ragnheidur Bragadottir

Ragnheidur Bragadottir

University of Oslo - Oslo / Norway
Medical and Health Sciences / Ophthalmology
AD Scientific Index ID: 1069119
Universitetet i Oslo
person_outline Ragnheidur Bragadottir's MOST POPULAR ARTICLES
1-) Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocolK Berg, TR Pedersen, L Sandvik, R BragadóttirOphthalmology 122 (1), 146-152, 20154012015
2-) Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dogK Narfström, ML Katz, R Bragadottir, M Seeliger, A Boulanger, ...Investigative ophthalmology & visual science 44 (4), 1663-1672, 20032892003
3-) Ranibizumab or bevacizumab for neovascular age-related macular degeneration according to the lucentis compared to avastin study treat-and-extend protocol: two-year resultsK Berg, E Hadzalic, I Gjertsen, V Forsaa, LH Berger, B Kinge, ...Ophthalmology 123 (1), 51-59, 20161612016
4-) In Vivo Gene Therapy in Young and Adult RPE65−/− Dogs Produces Long-Term Visual ImprovementK Narfström, ML Katz, M Ford, TM Redmond, E Rakoczy, R BragadottirJournal of Heredity 94 (1), 31-37, 20031522003
5-) An 8‐year follow‐up of anti‐vascular endothelial growth factor treatment with a treat‐and‐extend modality for neovascular age‐related macular degenerationK Berg, AB Roald, J Navaratnam, R BragadóttirActa ophthalmologica 95 (8), 796-802, 2017802017